tiprankstipranks
Trending News
More News >
iHuman (IH)
NYSE:IH
US Market

iHuman (IH) Ratios

Compare
82 Followers

iHuman Ratios

IH's free cash flow for Q3 2024 was ¥0.68. For the 2024 fiscal year, IH's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
2.82 2.23 2.10 2.56 0.89
Quick Ratio
2.78 2.20 2.04 2.52 0.78
Cash Ratio
2.47 1.87 1.77 2.16 0.57
Solvency Ratio
0.39 0.21 -0.06 -0.09 -1.50
Operating Cash Flow Ratio
0.35 2.30 0.08 0.56 0.23
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 889.75M¥ 689.84M¥ 522.73M¥ 617.17M¥ -19.70M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.03 <0.01 0.00
Debt-to-Equity Ratio
<0.01 0.01 0.06 0.01 0.00
Debt-to-Capital Ratio
<0.01 0.01 0.05 0.01 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.51 1.73 1.81 1.63 -11.65
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.01 0.03 0.13 0.03 0.00
Net Debt to EBITDA
-7.05 -8.50 17.17 20.54 0.38
Profitability Margins
Gross Profit Margin
70.84%70.13%69.93%68.70%61.51%
EBIT Margin
15.70%11.32%-5.74%-8.36%-127.51%
EBITDA Margin
16.85%12.42%-5.06%-7.83%-127.24%
Operating Profit Margin
15.70%11.32%-5.74%-8.36%-127.51%
Pretax Profit Margin
19.90%13.47%-3.94%-6.96%-125.42%
Net Profit Margin
17.77%11.14%-3.92%-7.05%-126.04%
Continuous Operations Profit Margin
17.77%11.14%-3.92%-7.05%-126.04%
Net Income Per EBT
89.30%82.71%99.61%101.26%100.50%
EBT Per EBIT
126.70%118.99%68.57%83.26%98.36%
Return on Assets (ROA)
12.47%8.24%-3.37%-3.58%-163.74%
Return on Equity (ROE)
18.89%14.27%-6.09%-5.83%1907.38%
Return on Capital Employed (ROCE)
16.66%14.45%-8.78%-6.86%1929.62%
Return on Invested Capital (ROIC)
14.85%11.86%-8.41%-6.93%1939.22%
Return on Tangible Assets
12.68%8.39%-3.45%-3.62%-163.84%
Earnings Yield
14.86%11.49%-3.94%-0.70%-5.46%
Efficiency Ratios
Receivables Turnover
16.25 12.03 16.02 6.79 10.42
Payables Turnover
13.41 12.16 9.30 7.72 8.17
Inventory Turnover
17.97 15.39 10.13 9.87 4.07
Fixed Asset Turnover
103.71 44.82 18.70 41.20 87.92
Asset Turnover
0.70 0.74 0.86 0.51 1.30
Working Capital Turnover Ratio
1.29 1.61 1.64 1.77 -5.16
Cash Conversion Cycle
15.55 24.03 19.60 43.46 79.97
Days of Sales Outstanding
22.46 30.33 22.79 53.72 35.03
Days of Inventory Outstanding
20.31 23.72 36.04 37.00 89.62
Days of Payables Outstanding
27.22 30.02 39.23 47.25 44.68
Operating Cycle
42.77 54.05 58.83 90.72 124.65
Cash Flow Ratios
Operating Cash Flow Per Share
0.63 4.85 0.14 0.99 0.19
Free Cash Flow Per Share
0.60 4.68 0.02 0.91 0.18
CapEx Per Share
0.02 0.17 0.12 0.07 0.01
Free Cash Flow to Operating Cash Flow
0.96 0.97 0.16 0.93 0.94
Dividend Paid and CapEx Coverage Ratio
26.44 28.61 1.18 2.72 7.76
Capital Expenditure Coverage Ratio
26.44 28.61 1.18 14.02 17.83
Operating Cash Flow Coverage Ratio
44.59 143.21 1.12 33.71 0.00
Operating Cash Flow to Sales Ratio
0.17 1.31 0.04 0.42 0.19
Free Cash Flow Yield
2.72%26.07%0.13%0.77%0.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
6.73 8.70 -25.41 -142.82 -18.30
Price-to-Sales (P/S) Ratio
1.20 0.97 1.00 10.06 23.06
Price-to-Book (P/B) Ratio
1.27 1.24 1.55 8.33 -349.02
Price-to-Free Cash Flow (P/FCF) Ratio
7.35 0.77 158.73 25.85 125.34
Price-to-Operating Cash Flow Ratio
7.08 0.74 24.64 24.00 118.31
Price-to-Earnings Growth (PEG) Ratio
0.11 -0.02 1.62 1.65 -0.01
Price-to-Fair Value
1.27 1.24 1.55 8.33 -349.02
Enterprise Value Multiple
0.05 -0.69 -2.51 -108.01 -17.75
EV to EBITDA
28.44 30.54 -81.24 -622.18 -90.25
EV to Sales
4.79 3.79 4.11 48.70 114.84
EV to Free Cash Flow
29.46 3.00 655.19 125.10 624.07
EV to Operating Cash Flow
28.35 2.90 101.69 116.18 589.07
Tangible Book Value Per Share
3.41 2.79 2.20 2.79 -0.06
Shareholders’ Equity Per Share
3.49 2.89 2.30 2.84 -0.06
Tax and Other Ratios
Effective Tax Rate
0.11 0.17 <0.01 -0.01 >-0.01
Revenue Per Share
3.71 3.70 3.57 2.35 0.97
Net Income Per Share
0.66 0.41 -0.14 -0.17 -1.22
Tax Burden
0.89 0.83 1.00 1.01 1.00
Interest Burden
1.27 1.19 0.69 0.83 0.98
Research & Development to Revenue
0.25 0.32 0.44 0.38 0.78
SG&A to Revenue
0.10 0.11 0.10 0.22 0.87
Stock-Based Compensation to Revenue
<0.01 0.09 0.02 0.15 1.24
Income Quality
0.95 1.72 -1.03 -5.95 -0.15
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis